2013
DOI: 10.4088/jcp.13f08826
|View full text |Cite
|
Sign up to set email alerts
|

Transcranial Direct Current Stimulation for Refractory Auditory Hallucinations in Schizophrenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
18
0
2

Year Published

2015
2015
2020
2020

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 35 publications
(21 citation statements)
references
References 40 publications
1
18
0
2
Order By: Relevance
“…tDCS may represent a well tolerated, inexpensive and promising treatment for antipsychoticrefractory VAH [39], although its putative efficacy is based on only one RCT [40]. Interestingly, the effect of tDCS on VAH may last longer than that of rTMS, and tDCS may also be effective for negative symptoms [40].…”
Section: Discussionmentioning
confidence: 99%
“…tDCS may represent a well tolerated, inexpensive and promising treatment for antipsychoticrefractory VAH [39], although its putative efficacy is based on only one RCT [40]. Interestingly, the effect of tDCS on VAH may last longer than that of rTMS, and tDCS may also be effective for negative symptoms [40].…”
Section: Discussionmentioning
confidence: 99%
“…A naturalistic study in 14 children with language disorders showed that 10 sessions of tDCS were well tolerated and the main side effect detected was irritability, followed by acute mood changes, tingling and itching [36] . However, due to anatomical and neurophysiological differences in the developing brain (i.e., skull thickness, cerebrospinal fluid volume, white and gray matter volumes) the dose parameters considered safe and efficacious for the use in adults should be adjusted to achieve comparable results in children [37] .…”
Section: Tdcs In the Major Depressive Disordermentioning
confidence: 99%
“…It is a safe and relatively inexpensive form of neurostimulation with clinically negligible adverse effects. tDCS with the cathode sited over the left TPC and the anode sited over the left DLPFC has been used for the treatment of medication-resistant AVH and for attenuation of negative symptom in schizophrenia [61]. Twice-daily tDCS with the above protocol has been found attenuate medication-refractory AVH in a randomized, sham controlled trial [62].…”
Section: Combining Tdcs With Clozapinementioning
confidence: 99%